Akoya Biosciences Profit Margin

Akoya Biosciences (AKYA) currently reports a profit margin of -59.45% as of March 2025. That compares with -72.68% in the prior-year period — up 18.2% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Akoya Biosciences's profit margin history and peer comparisons.

Akoya Biosciences's profit margin increased from -72.68% to -59.45% — a 18.2% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akoya Biosciences's profit margin of -59.45% is lower than the Healthcare sector average of 10.58%. That is roughly 661.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Akoya Biosciences's current -59.45% should be judged against Healthcare norms (sector average: 10.58%) and against AKYA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -59.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Akoya Biosciences, and consider following AKYA for alerts when major investors trade the stock.